Interpreter of Maladies: Application of Machine Learning to Precision Oncology
In this webinar, Emory University’s Dr. Anant Madabhushi will share how radiomic and pathomic approaches (derived from machine learning tools) can help predict disease outcome, recurrence, progression, and therapy response in the context of cancer.
Such approaches can assist your work in:
- prostate cancer.
- brain cancer.
- rectal cancer.
- oropharyngeal cancer.
- lung cancer.
Dr. Madabhushi and his team have been developing computerized knowledge alignment, representation, and fusion tools for integrating and correlating heterogeneous biological data. Such machine learning tools are valuable for precision oncology.
Dr. Madabhushi is a professor at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University. He also serves as executive director at the Emory Empathetic Artificial Intelligence (AI) for Health Institute. His team applies AI, radiomics, computational pathology, medical image analysis, and computer vision to the diagnosis, prognosis, and prediction of treatment responses across diseases (including cancer).
Upcoming Events
- Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncologyJuly 30, 2024CCDI Federated Data: Enhancing Data DiscoverabilityAugust 13, 2024Leveraging High-Performance Computing Resources and Using QIIME 2 to Advance Your Microbiome ProjectsAugust 27, 2024 - August 29, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024